Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Mb-Cart20.1
Acute Lymphoblastic Leukemia
Miltenyi Biomedicine GmbH
N/A
D
(30)
Mb-Cart20.1
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Miltenyi Biomedicine GmbH
N/A
D
(30)
Mb-Cart20.1
Melanoma
Miltenyi Biomedicine GmbH
N/A
D
(30)
Mb-Cart20.1
Childhood Acute Lymphoblastic Leukemia
Miltenyi Biomedicine GmbH
N/A
D
(30)
NKG2D CAR-NK
Acute Myeloid Leukemia
Zhejiang University
N/A
D
(30)
nkg2d car-t
Glioblastoma
UWELL Biopharma
N/A
D
(30)
pd1-bcma-cart
Plasma Cell Myeloma
Bioray Laboratories
N/A
D
(30)
Showing 2676 to 2700 of 3,186 assets
Previous
Page 108 of 128
Next